Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Targeting colon cancer stem cells might lead to better treatment results.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Some medications can cause acne, and stopping these drugs is the main treatment.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Type I interferons play a key role in the development of various skin diseases.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Natural products can help overcome cancer drug resistance.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Erlotinib can cause hair loss as a side effect.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.